Catalyst Wire Dossier Catalyst Wire Dossier

GEMTESA

VIBEGRON · Sumitomo Pharma America, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GEMTESA, covering 2020-12-23 to 2024-12-18. Get the full timeline:

Most recent: FDA Approved: GEMTESA — Supplemental Application (Sumitomo Pharma America, Inc.)

See pricing